Free Trial

eFFECTOR Therapeutics (EFTR) Competitors

eFFECTOR Therapeutics logo
$0.0002 0.00 (-33.33%)
As of 07/3/2025 09:43 AM Eastern

EFTR vs. CLVR, ONCSQ, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, and ACABW

Should you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include Clever Leaves (CLVR), OncoSec Medical (ONCSQ), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry.

eFFECTOR Therapeutics vs. Its Competitors

Clever Leaves (NASDAQ:CLVR) and eFFECTOR Therapeutics (NASDAQ:EFTR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled eFFECTOR Therapeutics'average media sentiment score.

Company Overall Sentiment
Clever Leaves Neutral
eFFECTOR Therapeutics Neutral

6.9% of Clever Leaves shares are held by institutional investors. Comparatively, 57.7% of eFFECTOR Therapeutics shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Comparatively, 4.7% of eFFECTOR Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Clever Leaves has a beta of 3440.04, suggesting that its share price is 343,904% more volatile than the S&P 500. Comparatively, eFFECTOR Therapeutics has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.

Clever Leaves has higher revenue and earnings than eFFECTOR Therapeutics. eFFECTOR Therapeutics is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.00-$17.90M-$11.31N/A
eFFECTOR TherapeuticsN/AN/A-$35.81M-$13.080.00

Company Net Margins Return on Equity Return on Assets
Clever LeavesN/A N/A N/A
eFFECTOR Therapeutics N/A N/A N/A

Summary

Clever Leaves beats eFFECTOR Therapeutics on 6 of the 7 factors compared between the two stocks.

Get eFFECTOR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EFTR and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EFTR vs. The Competition

MetriceFFECTOR TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$798.01M$5.53B$9.02B
Dividend YieldN/A4.84%5.22%3.99%
P/E Ratio0.001.3727.7920.25
Price / SalesN/A230.41426.06119.26
Price / CashN/A23.4426.2128.59
Price / Book0.006.328.045.65
Net Income-$35.81M-$27.99M$3.18B$249.15M
7 Day PerformanceN/A2.32%2.89%2.91%
1 Month PerformanceN/A9.07%1.67%4.11%
1 Year PerformanceN/A11.51%34.53%20.98%

eFFECTOR Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EFTR
eFFECTOR Therapeutics
N/A$0.00
-33.3%
N/A-99.8%$1KN/A0.0010Gap Up
CLVR
Clever Leaves
N/A$0.00
flat
N/AN/A$1K$17.42M0.00560
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1KN/A0.0040
PXMD
PaxMedica
N/A$0.00
flat
N/AN/A$1KN/A0.002
ATNFW
180 Life Sciences
N/A$0.01
+2.5%
N/A-6.9%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.15
flat
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.70
+13.3%
N/A-41.9%$0.00$585.60M0.004
AMPE
Ampio Pharmaceuticals
0.0579 of 5 stars
$0.00
-96.3%
N/AN/A$0.00N/A0.0020
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-0.5%
N/AN/A$0.00N/A0.0015

Related Companies and Tools


This page (NASDAQ:EFTR) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners